Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Garner

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 28, 2024
Latent Tuberculosis Infection Amongst Allogeneic Hematopoietic Stem Cell Transplant Recipients: The Impact of Routine Pretransplant Review by a Transplant Infectious Diseases PhysicianGabriel Paykin, Sara Vogrin, Peter Shuttleworth, et al.
Orphanet Journal of Rare Diseases|February 12, 2014
Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectivesDavid Uguen, Thomas Lönngren, Yann Le Cam, et al.
The Journal of Hospital Infection|May 8, 2025
Predictors of early line removal and successful line retention in potential central line-associated blood stream infections (CLABSIs) in haematology patients: A retrospective cohort studySamuel Thorburn, Sara Vogrin, Sarah Garner, et al.
Frontiers in Pharmacology|October 18, 2021
Corrigendum: Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications From ESAC-Net and WHO EuropeJane Robertson, Vera Vlahović-Palčevski, Kotoji Iwamoto, et al.
Frontiers in Pharmacology|July 5, 2021
Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO EuropeJane Robertson, Vera Vlahović-Palčevski, Kotoji Iwamoto, et al.
Research Synthesis Methods|June 9, 2015
Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventionsSusan L Norris, David Moher, Barnaby C Reeves, et al.
Lancet (London, England)|August 2, 2018
The drugs don't work: WHO's role in advancing new antibioticsPeter Beyer, Vasee Moorthy, Sarah Paulin, et al.
Emerging Infectious Diseases|September 7, 2023
Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022Rebecca E Harrison, Ahmed Hamada, Nujcharee Haswell, et al.
Pharmacoeconomics|June 7, 2015
Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International ReviewBonny Parkinson, Catherine Sermet, Fiona Clement, et al.
International Journal of Antimicrobial Agents|December 4, 2014
Emergence of blaKPC carbapenemase genes in AustraliaSally R Partridge, Andrew N Ginn, Agnieszka M Wiklendt, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 28, 2024
Latent Tuberculosis Infection Amongst Allogeneic Hematopoietic Stem Cell Transplant Recipients: The Impact of Routine Pretransplant Review by a Transplant Infectious Diseases PhysicianGabriel Paykin, Sara Vogrin, Peter Shuttleworth, et al.
Orphanet Journal of Rare Diseases|February 12, 2014
Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectivesDavid Uguen, Thomas Lönngren, Yann Le Cam, et al.
The Journal of Hospital Infection|May 8, 2025
Predictors of early line removal and successful line retention in potential central line-associated blood stream infections (CLABSIs) in haematology patients: A retrospective cohort studySamuel Thorburn, Sara Vogrin, Sarah Garner, et al.
Frontiers in Pharmacology|October 18, 2021
Corrigendum: Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications From ESAC-Net and WHO EuropeJane Robertson, Vera Vlahović-Palčevski, Kotoji Iwamoto, et al.
Frontiers in Pharmacology|July 5, 2021
Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO EuropeJane Robertson, Vera Vlahović-Palčevski, Kotoji Iwamoto, et al.
Research Synthesis Methods|June 9, 2015
Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventionsSusan L Norris, David Moher, Barnaby C Reeves, et al.
Lancet (London, England)|August 2, 2018
The drugs don't work: WHO's role in advancing new antibioticsPeter Beyer, Vasee Moorthy, Sarah Paulin, et al.
Emerging Infectious Diseases|September 7, 2023
Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022Rebecca E Harrison, Ahmed Hamada, Nujcharee Haswell, et al.
Pharmacoeconomics|June 7, 2015
Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International ReviewBonny Parkinson, Catherine Sermet, Fiona Clement, et al.
International Journal of Antimicrobial Agents|December 4, 2014
Emergence of blaKPC carbapenemase genes in AustraliaSally R Partridge, Andrew N Ginn, Agnieszka M Wiklendt, et al.
Pageof 5